Publicaciones en las que colabora con Ana María Fernández Rodríguez (15)

2019

  1. Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized transform study

    Transplantation, Vol. 103, Núm. 9, pp. 1953-1963

2011

  1. Efficacy and safety of conversion from twice-daily to once-daily tacrolimus in a large cohort of stable kidney transplant recipients

    American Journal of Transplantation, Vol. 11, Núm. 9, pp. 1965-1971

2007

  1. Randomized controlled study comparing reduced calcineurin inhibitors exposure versus standard cyclosporine-based immunosuppression

    Transplantation, Vol. 84, Núm. 6, pp. 706-714

2006

  1. Impact of Metabolic Syndrome on Graft Function and Survival After Cadaveric Renal Transplantation

    American Journal of Kidney Diseases, Vol. 48, Núm. 1, pp. 134-142

  2. Nefrología basada en investigación clínica: Bases conceptuales para la constitución de un grupo de trabajo en Nefrología Basada en la Evidencia de la Sociedad Española de Nefrología

    Nefrologia, Vol. 26, Núm. 2, pp. 163-172

1999

  1. The Pl(A2) polymorphism of the platelet glycoprotein IIIA gene as a risk factor for acute renal allograft rejection

    Journal of the American Society of Nephrology, Vol. 10, Núm. 12, pp. 2599-2605

1998

  1. Automated peritoneal dialysis: A Spanish multicentre study

    Nephrology Dialysis Transplantation, Vol. 13, Núm. 9, pp. 2335-2340

1995

  1. Clinical and immune aspects of idiopathic acute tubulointerstitial nephritis and uveitis syndrome

    American Journal of Nephrology, Vol. 15, Núm. 5, pp. 386-391

1992

  1. Could CAPD modulate the hemodynamic changes induced by rHuEPO treatment?

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 8, pp. 435-439

  2. ESTUDIO CONTROLADO DE LA OSTEODISTROFIA RENAL EN DIALISIS PERITONEAL CONTINUA AMBULATORIA (DPCA). ANALISIS CLINICO, BIOQUIMICO, RADIOLOGICO E HISTOMORFOMETRICO

    Nefrologia, Vol. 12, Núm. 4, pp. 330-339

  3. EVALUACION DEL COMPORTAMIENTO PERITONEAL A MEDIO PLAZO DESPUES DEL TRATAMIENTO CON ERITROPOYETINA

    Nefrologia, Vol. 12, Núm. SUPPL. 1, pp. 99-105

  4. Effect of recombinant human erythropoietin treatment on hemodynamic parameters in continuous ambulatory peritoneal dialysis and hemodialysis patients

    American Journal of Nephrology, Vol. 12, Núm. 4, pp. 208-211

  5. Low turnover bone disease is the more common form of bone disease in CAPD patients.

    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, Vol. 8, pp. 376-380

  6. MODIFICACIONES HEMODINAMICAS INDUCIDAS POR EL TRATAMIENTO CON ERITROPOYETINA DURANTE UN ANO

    Nefrologia, Vol. 12, Núm. SUPPL. 1, pp. 94-98

1991

  1. Arterial calcification in diabetic patients undergoing CAPD.

    Contributions to nephrology, Vol. 89, pp. 205-213